At a glance
The Division of Tuberculosis (TB) Elimination publishes Dear Colleague Letters from the Division to partners about TB updates. Dear Colleague Letters are available from the past two years.

2024
ÐÇ¿ÕÓéÀÖ¹ÙÍø published "Reported Tuberculosis in the United States, 2023."
"Tuberculosis — United States, 2023" has information on provisional U.S. TB disease cases in 2023.
2023
ÐÇ¿ÕÓéÀÖ¹ÙÍø's Tuberculosis Trials Consortium (TBTC) launched a new international clinical trial.
ÐÇ¿ÕÓéÀÖ¹ÙÍø published "Reported Tuberculosis in the United States, 2022."
ÐÇ¿ÕÓéÀÖ¹ÙÍø announced new resources about the Uniting for Ukraine program TB screening requirements.
Beginning May 24, 2023, ÐÇ¿ÕÓéÀÖ¹ÙÍø implemented rapid testing for fluoroquinolone (FQ) resistance.
ÐÇ¿ÕÓéÀÖ¹ÙÍø encourages TB program to take proactive measures to reduce drug supply interruptions.
ÐÇ¿ÕÓéÀÖ¹ÙÍø updated the 2022 Provisional Guidance for the BPaL Regimen to Treat Drug-resistant TB Disease.
Read a message for World TB Day 2023 from Dr. Rochelle P. Walensky, ÐÇ¿ÕÓéÀÖ¹ÙÍø Director.
ÐÇ¿ÕÓéÀÖ¹ÙÍø's Division of TB Elimination shares information to assist in World TB Day 2023 planning efforts.